Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK/NF-κB signaling pathwayZhichao Liu(Nankai University), Honggang Zhou(Nankai University)Research SquareFebruary 21, 202410.21203/rs.3.rs-3921405/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersFOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis|Research Square|2021|4Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway|Biomolecules|2025|1